Delivery of therapeutic small interfering RNA: The current patent-based landscape

Delivery of therapeutic small interfering RNA: The current patent-based landscape

Implementing small interfering RNA (siRNA) is a promising therapy because it silences disease-related genes theoretically. However, the efficient delivery of siRNA is challenging, which limits its therapeutic applications. Various pharmaceutical delivery systems containing key technologies have been...

Full description

Bibliographic Details
Main Authors:	Yu Chen, Shi-Hang Xiong, Fei Li, Xiang-Jun Kong, De-Fang Ouyang, Ying Zheng, Hua Yu, Yuan-Jia Hu
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	Molecular Therapy: Nucleic Acids
Subjects:	therapeutic siRNA delivery technology patent landscape
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253122001639

Similar Items

siRNA therapeutics and its challenges: Recent advances in effective delivery for cancer therapy
by: Arpita Paul, et al.
Published: (2022-07-01)

Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
by: Xin-Qi Teng, et al.
Published: (2022-07-01)

Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection
by: Esinam E. Agbosu, et al.
Published: (2022-06-01)

Design of siRNA Therapeutics from the Molecular Scale
by: Christina Chan, et al.
Published: (2013-03-01)

Drug Discovery, Diagnostic, and therapeutic trends on Mpox: A patent landscape
by: Rohit Sharma, et al.
Published: (2024-01-01)

Engineering siRNA therapeutics: challenges and strategies
by: Syed Saqib Ali Zaidi, et al.
Published: (2023-10-01)

Dendrimers for siRNA Delivery
by: Swati Biswas, et al.
Published: (2013-02-01)

Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
by: Wanyi Tai
Published: (2019-06-01)

Recent advances in using liposomes for delivery of nucleic acid-based therapeutics
by: Hamdi Nsairat, et al.
Published: (2023-05-01)

RNA Interference and its therapeutic applications
by: Srinivasa Rao T, et al.
Published: (2011-10-01)

Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease
by: Marc Suñé-Pou, et al.
Published: (2020-07-01)

Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors
by: Pasquale Losurdo, et al.
Published: (2022-10-01)

Two Birds with One Stone: A Novel Dithiomaleimide-Based GalNAc-siRNA Conjugate Enabling Good siRNA Delivery and Traceability
by: Sudong Kong, et al.
Published: (2023-10-01)

Overview of RNA interference therapeutics
by: Nattanan T-Thienprasert Panjaworayan
Published: (2012-07-01)

Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers
by: Thakur Ajit, et al.
Published: (2012-06-01)

Liposome-Based Drug Delivery Systems in Cancer Research: An Analysis of Global Landscape Efforts and Achievements
by: Islam Hamad, et al.
Published: (2024-03-01)

Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect
by: Yang X, et al.
Published: (2018-07-01)

Advances in Nanomaterials Used in Co-Delivery of siRNA and Small Molecule Drugs for Cancer Treatment
by: Shei Li Chung, et al.
Published: (2021-09-01)

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
by: Achim Aigner, et al.
Published: (2011-12-01)

Antibody–siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022-09-01)

Gene Silencing in Skin After Deposition of Self-Delivery siRNA With a Motorized Microneedle Array Device
by: Robyn P Hickerson, et al.
Published: (2013-01-01)

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA
by: Priyanga Ranasinghe, et al.
Published: (2022-10-01)

The global mRNA vaccine patent landscape
by: Mengyao Li, et al.
Published: (2022-11-01)

Co-Delivery of Repurposing Itraconazole and VEGF siRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer
by: Mingji Jin, et al.
Published: (2022-06-01)

Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness
by: Rossella Farra, et al.
Published: (2018-03-01)

Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
by: Sepideh Mirzaei, et al.
Published: (2021-11-01)

Implications of siRNA Therapy in Bone Health: Silencing Communicates
by: Puneetpal Singh, et al.
Published: (2024-01-01)

A Multifunctional Hybrid Nanocarrier for Non-Invasive siRNA Delivery to the Retina
by: Shogo Nishida, et al.
Published: (2023-02-01)

Nanocarrier Lipid Composition Modulates the Impact of Pulmonary Surfactant Protein B (SP-B) on Cellular Delivery of siRNA
by: Roberta Guagliardo, et al.
Published: (2019-08-01)

Tumor-targeted delivery of siRNA to silence Sox2 gene expression enhances therapeutic response in hepatocellular carcinoma
by: Yu Xia, et al.
Published: (2021-05-01)

Delivery systems for siRNA drug development in cancer therapy
by: Cong-fei Xu, et al.
Published: (2015-02-01)

A model system for antiviral siRNA therapeutics using exosome-based delivery
by: Margaret Wallen, et al.
Published: (2022-09-01)

RNA Interference as a Prospective Tool for the Control of Human Viral Infections
by: Alesia Levanova, et al.
Published: (2018-09-01)

Current progress of RNA aptamer-based therapeutics
by: Jiehua eZhou, et al.
Published: (2012-11-01)

STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape
by: Xiangjun Kong, et al.
Published: (2023-02-01)

Development of therapeutic-grade small interfering RNAs by chemical engineering
by: Jesper Bertram Bramsen, et al.
Published: (2012-08-01)

What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review
by: Kunmeng Liu, et al.
Published: (2022-07-01)

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
by: Peter Järver, et al.
Published: (2012-01-01)

Silver Nanoparticles Modified by Carbosilane Dendrons and PEG as Delivery Vectors of Small Interfering RNA
by: Viktar Abashkin, et al.
Published: (2023-01-01)

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
by: Benedikt Linder, et al.
Published: (2019-03-01)